Health care in a post-pandemic world: Telehealth is here to stay, but so are in-person visits

guest article

What's the future of telehealth as we emerge out of the pandemic? This guest contributor weighs in. Photo via Getty Images

As medical practitioners were faced with the abrupt arrival of the pandemic, they had to immediately adapt to new technologies and switch to telehealth – fundamentally changing the way healthcare is delivered. During the first few months of the pandemic, many private practices were forced to close their doors. Some have since opened with limited schedules, but many are still feeling the effects linger.

Telehealth has grown in popularity due to the efficiency and convenience it offers to both patients and providers. A recent CDC report noted that 30 percent of weekly health care visits occurred via telehealth from June to November 2020. According to the Health Center Program Data, 43 percent of health centers were capable of providing telehealth in 2019, compared to 95 percent of health centers using telehealth during the COVID-19 pandemic.

As patients and healthcare institutions navigate this remote landscape, many challenges need to be addressed. Particularly, the rules and regulations that govern telehealth and how to ensure telehealth platforms can be used safely to offer care. Beyond policies and laws, there are several infrastructure hurdles affecting the implementation of telehealth services in rural areas, making this population vulnerable to inadequate access to care. The same CDC report noted that rural areas reported the lowest average of weekly health care visits via telehealth.

Practitioners also face new challenges evaluating and diagnosing patients without having the ability to do a hands-on physical exam and access to vitals such as blood pressure, heart rate and temperature during virtual visits. Telehealth visits are no match for direct, inpatient clinical visits, but practitioners are still trying to find its role in our current healthcare system.

Some of the ways we've integrated a technology-driven approach to healthcare at WellnessSpace is through putting together the best of both worlds. We focus on in-person visits that have the convenience of technology to enhance the experience of both members and their clients. We use client self-check-in kiosks, an interactive mobile app that allows our members to reserve suites on-demand, download invoices, manage their bios and message other members. We are focusing on providing an easy and integrated experience for both patients and practitioners, which is something that will play a key role in how practitioners and patients navigate the "new normal" as we move forward.

We can expect telehealth to continue to play a vital role in providing healthcare, but for the vast majority of practices, telehealth will supplement in-person visits, not replace them. In a release from the Department of Health and Human Services, surveyed practitioners expect telehealth to remain at 21 percent compared to 51 percent during the pandemic.

Overall, the pandemic has opened the doors for telehealth and increased its adoption among all age groups. It's provided an alternative for practitioners to still offer care, just in a different way. While it's not ideal for all situations, this technology is a tool that can help practitioners continue what they do best – helping patients.

------

Sunny Somaiya is the co-owner of Houston-based WellnessSpace.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston's Ion District to expand with new research and tech space, The Arc

coming soon

Houston's Ion District is set to expand with the addition of a nearly 200,000-square-foot research and technology facility, The Arc at the Ion District.

Rice Real Estate Company and Lincoln Property Company are expected to break ground on the state-of-the-art facility in Q2 2026 with a completion target set for Q1 2028, according to a news release.

Rice University, the new facility's lead tenant, will occupy almost 30,000 square feet of office and lab space in The Arc, which will share a plaza with the Ion and is intended to "extend the district’s success as a hub for innovative ideas and collaboration." Rice research at The Arc will focus on energy, artificial intelligence, data science, robotics and computational engineering, according to the release.

“The Arc will offer Rice the opportunity to deepen its commitment to fostering world-changing innovation by bringing our leading minds and breakthrough discoveries into direct engagement with Houston’s thriving entrepreneurial ecosystem,” Rice President Reginald DesRoches said in the release. “Working side by side with industry experts and actual end users at the Ion District uniquely positions our faculty and students to form partnerships and collaborations that might not be possible elsewhere.”

Developers of the project are targeting LEED Gold certification by incorporating smart building automation and energy-saving features into The Arc's design. Tenants will have the opportunity to lease flexible floor plans ranging from 28,000 to 31,000 square feet with 15-foot-high ceilings. The property will also feature a gym, an amenity lounge, conference and meeting spaces, outdoor plazas, underground parking and on-site retail and dining.

Preleasing has begun for organizations interested in joining Rice in the building.

“The Arc at the Ion District will be more than a building—it will be a catalyst for the partnerships, innovations and discoveries that will define Houston’s future in science and technology,” Ken Jett, president of Rice Real Estate Company, added in the release. “By expanding our urban innovation ecosystem, The Arc will attract leading organizations and talent to Houston, further strengthening our city’s position as a hub for scientific and entrepreneurial progress.”

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”
View All Listings